{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:50:08Z","timestamp":1793407808249,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Chronic pain and substance use disorders frequently co-occur. Indeed, chronic pain is highly prevalent, affecting 23\u201368% of patients receiving opioid agonist treatments (OAT) worldwide. The majority of available estimates come from American studies, but data are still lacking in Europe. We aim to provide European estimates of the prevalence of chronic pain in patients receiving OAT using French data, since France is the first European country in terms of number of patients with OAT. The secondary objectives were to characterize the features and management of chronic pain, as well identify associated risk factors. We conducted a multicenter, cross-sectional study, recruiting patients treated either with buprenorphine or methadone in 19 French addiction centers, from May to July 2016. All participants had to complete a semi-directed questionnaire that collected sociodemographic and medical data, pain characteristics, and licit or illicit drug consumption. In total, 509 patients were included. The prevalence of chronic pain was estimated at 33.2% (95% CI: 29.1\u201337.3). Compared to non-chronic pain patients, chronic pain patients were older (38.4 vs. 36.1 years, <jats:italic>p<\/jats:italic> = 0.006), were more unemployed (66 vs. 52%, <jats:italic>p<\/jats:italic> = 0.003), had more psychiatric comorbidities (50 vs. 39%, <jats:italic>p<\/jats:italic> = 0.02), and split their OAT for pain management more frequently (24 vs. 7%, <jats:italic>p<\/jats:italic> = 0.009). Pain intensity was moderate or severe in 75% of chronic pain patients. Among patients with chronic pain, 15.4% were not prescribed, and did not self-medicate with, any analgesic drugs, 52.1% were prescribed analgesics (non-opioid analgesics, 76.3%; codeine, tramadol, opium, 27.2%; and morphine, fentanyl, oxycodone, 11.8%), and 32.5% exclusively self-medicated with analgesics. Moreover, 20.1% of patients with chronic pain also used illicit drugs for pain relief. On multivariate analysis, variables that remained significantly associated with chronic pain were age [OR = 1.03 (95% CI: 1.00\u20131.05], <jats:italic>p<\/jats:italic> = 0.02], anxiety [OR = 1.52 (1.15\u20132.02), <jats:italic>p<\/jats:italic> = 0.003], and depression [OR = 1.25 (1.00\u20131.55), <jats:italic>p<\/jats:italic> = 0.05]. Chronic pain is a highly prevalent condition in patients receiving OAT, and its appropriate management remains uncertain, since insufficient relief and frequent additional self-medications with analgesics or illicit drugs were reported by these patients. Increased awareness among caregivers is urgently needed regarding a systematic and careful assessment, along with an adequate management of chronic pain in patients receiving OAT.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.641430","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:03:50Z","timestamp":1619413430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Jessica","family":"Delorme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Pennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Daulou\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Delile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Dematteis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Kabore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TOXIDOL Study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.289.18.2370","article-title":"Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities","volume":"289","author":"Rosenblum","year":"2003","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pain.2004.11.011","article-title":"Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain","volume":"113","author":"Peles","year":"2005","journal-title":"Pain."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4088\/JCP.08m04367","article-title":"Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients","volume":"70","author":"Barry","year":"2009","journal-title":"J Clin Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/10550490902772470","article-title":"Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment","volume":"18","author":"Barry","year":"2009","journal-title":"Am J Addict."},{"key":"B5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1521-0391.2012.00327.x","article-title":"Pain and associated substance use among opioid dependent individuals seeking office-based treatment with buprenorphine-naloxone: a needs assessment study","volume":"22","author":"Barry","year":"2013","journal-title":"Am J Addict."},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.drugalcdep.2015.10.018","article-title":"Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients","volume":"157","author":"Dunn","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"B7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s11606-015-3212-y","article-title":"Chronic pain and depressionamong primary care patients treated with buprenorphine","volume":"30","author":"Stein","year":"2015","journal-title":"J Gen Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/08897077.2015.1135225","article-title":"Characteristics of methadone maintenance treatment patients prescribed opioid analgesics","volume":"37","author":"Glenn","year":"2016","journal-title":"Subst Abus."},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugalcdep.2016.06.024","article-title":"Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy","volume":"166","author":"Tsui","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/j.pain.0000000000002011","article-title":"Prevalence of chronic pain in opioid-maintained patients using the capture-recapture method: a nationwide population-based study","volume":"162","author":"Delorme","year":"2020","journal-title":"Pain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/j.pain.0000000000001009","article-title":"Defining chronic pain in epidemiological studies - a systematic review and meta-analysis","volume":"158","author":"Steingr\u00edmsd\u00f3ttir","year":"2017","journal-title":"Pain."},{"key":"B12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0885-3924(99)00144-X","article-title":"Characteristics of methadone maintenance patients with chronic pain","volume":"19","author":"Jamison","year":"2000","journal-title":"J Pain Sympt Manag."},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2012.08.003","article-title":"Epidemiology of pain among outpatients in methadone maintenance treatment programs","volume":"128","author":"Dhingra","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/dar.12041","article-title":"Correlates of pain in an in-treatment sample of opioid-dependent people","volume":"32","author":"Nielsen","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11606-009-0908-x","article-title":"Providers' experiences treating chronic pain among opioid-dependent drug users","volume":"24","author":"Berg","year":"2009","journal-title":"J Gen Intern Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/ADM.0b013e31815ec240","article-title":"Counselors' experiences treating methadone-maintained patients with chronic pain: a needs assessment study","volume":"2","author":"Barry","year":"2008","journal-title":"J Addict Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1093\/pm\/pnw327","article-title":"Drug counselor responses to patients' pain reports: a qualitative investigation of barriers and facilitators to treating patients with chronic pain in methadone maintenance treatment","volume":"18","author":"Beitel","year":"2017","journal-title":"Pain Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11606-002-0034-5","article-title":"Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill","year":"2002","journal-title":"J Gen Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pmn.2005.12.003","article-title":"Knowing how to play the game: hospitalized substance abusers' strategies for obtaining pain relief","volume":"7","author":"Morgan","year":"2006","journal-title":"Pain Manag Nurs."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/pme.12493","article-title":"Health care experiences when pain and substance use disorder coexist: \u201cjust because i'm an addict doesn't mean i don't have pain","volume":"15","author":"St Marie","year":"2014"},{"key":"B21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fpsyt.2018.00335","article-title":"Chronic pain opioid-maintained patients receive less analgesic opioid prescriptions","volume":"9","author":"Delorme","year":"2018","journal-title":"Front Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"E739","DOI":"10.36076\/ppj.2013\/16\/E739","article-title":"Long-term consequences of acute pain for patients under methadone or buprenorphine maintenance treatment","volume":"16","author":"Bounes","year":"2013","journal-title":"Pain Physician."},{"key":"B23","unstructured":"Understanding the Epidemic2020"},{"key":"B24","unstructured":"ObservatoireFran\u00e7ais des Drogues et des Toxicomanies\n          Tableau de bord \u201cTraitements de substitution aux opiac\u00e9s\u201d 20202020"},{"key":"B25","volume-title":"European Drug Report 2020: Trends and Developments","year":"2020"},{"key":"B26","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap."},{"key":"B27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/107319110000700201","article-title":"Six- and ten-item indexes of psychological distress based on the Symptom Checklist-90","volume":"7","author":"Rosen","year":"2000","journal-title":"Assessment."},{"key":"B28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jpain.2015.06.003","article-title":"Pain among high-risk patients on methadone maintenance treatment","volume":"16","author":"Voon","year":"2015","journal-title":"J Pain."},{"key":"B29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0885-3924(00)00191-3","article-title":"Pain responses in methadone-maintained opioid abusers","volume":"20","author":"Compton","year":"2000","journal-title":"J Pain Symptom Manage."},{"key":"B30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0304-3959(00)00391-2","article-title":"Hyperalgesic responses in methadone maintenance patients","volume":"90","author":"Doverty","year":"2001","journal-title":"Pain."},{"key":"B31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpain.2008.10.003","article-title":"Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients","volume":"10","author":"Hay","year":"2009","journal-title":"J Pain."},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpain.2010.04.009","article-title":"The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment","volume":"12","author":"Peles","year":"2011","journal-title":"J Pain."},{"key":"B33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.18433\/J3NS49","article-title":"Comparison of pain tolerance between opioid dependent patients on methadone maintenance therapy (MMT) and opioid naive individuals","volume":"19","author":"Zahari","year":"2016","journal-title":"J Pharm Pharm Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4088\/JCP.15m09963","article-title":"Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder","volume":"77","author":"Barry","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2003.08.007","article-title":"Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment","volume":"73","author":"Trafton","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/ADM.0b013e3181ac913a","article-title":"Conventional and nonconventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: a needs assessment study","volume":"4","author":"Barry","year":"2010","journal-title":"J Addict Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/J354v16n01_09","article-title":"Opiophobia as a barrier to the treatment of pain","volume":"16","author":"Bennett","year":"2002","journal-title":"J Pain Palliat Care Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/08897077.2011.630944","article-title":"Practices, perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain","volume":"33","author":"Keller","year":"2012","journal-title":"Subst Abus."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1080\/14656566.2019.1652270","article-title":"Pain management in opioid maintenance treatment","volume":"20","author":"Koller","year":"2019","journal-title":"Expert Opin Pharmacother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/pme.12430","article-title":"Severity and interference of chronic pain in methadone-maintained outpatients","volume":"15","author":"Dunn","year":"2014","journal-title":"Pain Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4137\/SART.S30120","article-title":"Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis","volume":"9","author":"Dennis","year":"2015","journal-title":"Subst Abuse."},{"key":"B42","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/oxfordjournals.schbul.a033351","article-title":"Review of integrated mental health and substance abuse treatment for patients with dual disorders","volume":"24","author":"Drake","year":"1998","journal-title":"Schizophr Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/JCP.0706e01","article-title":"Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness","volume":"67","author":"Buckley","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7916\/D8S75FMX","article-title":"Chronic pain, mental health and substance use disorders: how can we manage this triad in our healthcare systemand in our communities?","volume":"1","author":"Ross","year":"2015","journal-title":"Columbia Med Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/fcp.12024","article-title":"OPPIDUM surveillance program: 20 years of information on drug abuse in France","volume":"27","author":"Frauger","year":"2013","journal-title":"Fundam Clin Pharmacol."},{"key":"B46","unstructured":"ObservatoireFran\u00e7ais des Drogues et des Toxicomanes\n          Les traitements de substitution aux opiac\u00e9s : donn\u00e9es r\u00e9centes2014"},{"key":"B47","unstructured":"Centred'Addictovigilance\n          Observation des Produits Psychotropes Illicites ou D\u00e9tourn\u00e9s de leur Utilisation M\u00e9dicamenteuse (OPPIDUM)2016"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.641430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T05:04:03Z","timestamp":1619413443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.641430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":47,"alternative-id":["10.3389\/fpsyt.2021.641430"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.641430","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]},"article-number":"641430"}}